直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan

Search Finnegan

Our Insights

9 results

Articles

TOPCon v. Back-Contact Solar Cells: The Technology Race Fueled by Patent Strategy, Enforcement and Licensing

TOPCon v. Back-Contact Solar Cells: The Technology Race Fueled by Patent Strategy, Enforcement and Licensing TOPCon v. Back-Contact Solar Cells: The Technology Race Fueled by Patent Strategy, Enforcement and Licensing

April 27, 2026

Intellectual Asset Management (IAM)

Lecture

2025 IP (Intellectual Property) Due Diligence & Freedom to Operate in Practice Training Course 2025 IP (Intellectual Property) Due Diligence & Freedom to Operate in Practice Training Course

March 6-7, 2025

Webinar

Conference

2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities 2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities

March 20, 2024

Boston

Articles

Don’t Be the Cyber Company That Fails to Protect Your Inventions!

Don’t Be the Cyber Company That Fails to Protect Your Inventions! Don’t Be the Cyber Company That Fails to Protect Your Inventions!

January 30, 2023

Haaretz Cyber Magazine

Articles

Top Five Things Cosmetic Companies Need to Know When Adopting AI/AR Tech

Top Five Things Cosmetic Companies Need to Know When Adopting AI/AR Tech Top Five Things Cosmetic Companies Need to Know When Adopting AI/AR Tech

October 11, 2021

HAPPI Magazine

Webinar

Practical Advice Regarding Due Diligence and Freedom to Operate Opinions

Practical Advice Regarding Due Diligence and Freedom to Operate Opinions Practical Advice Regarding Due Diligence and Freedom to Operate Opinions

June 17, 2020

Webinar

Articles

What Are the Priority Date, Patent Term, and Effective Filing Date of a Patent: The Roles of Specific Reference, Incorporation by Reference, and Claim Support What Are the Priority Date, Patent Term, and Effective Filing Date of a Patent: The Roles of Specific Reference, Incorporation by Reference, and Claim Support

October 30, 2018

IPWatchdog

Articles

Post-Grant Proceedings as a Freedom-To-Operate Tool Post-Grant Proceedings as a Freedom-To-Operate Tool

October 30, 2017

Law360

News

2 results

Media Mention

PTAB 4 Years In: Biotech/Pharma's Share of AIA Trials Increases PTAB 4 Years In: Biotech/Pharma's Share of AIA Trials Increases

September 16, 2016

Managing Intellectual Property

Media Mention

GC Roundtable: The New Frontiers of IP, London GC Roundtable: The New Frontiers of IP, London

Spring 2016

GC Magazine

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP